Detection and Evaluation of Renal Injury in Burst Wave Lithotripsy Using Ultrasound and Magnetic Resonance Imaging.
Philip C May, Wayne Kreider, Adam D Maxwell...
https://pubmed.ncbi.nlm.nih.gov/28521550Actively Recruiting
Led by University of Washington · Updated on 2026-05-13
40
Participants Needed
2
Research Sites
17 weeks
Total Duration
U
University of Washington
Lead Sponsor
I
Indiana University
Collaborating Sponsor
Burst Wave Lithotripsy (BWL) is a new technique being studied to break up kidney and ureteral stones using repeated bursts of low-amplitude ultrasound. Unlike traditional shock wave lithotripsy, which uses a single high-energy shock wave, BWL applies multiple cycles of sound waves to fracture stones. This single-arm feasibility study aims to test how well BWL can fragment stones in humans during surgery. The study involves one group where participants receive BWL treatment during a standard ureteroscopic laser stone removal procedure while under anesthesia. Stones treated are limited to 12 mm or smaller. The BWL device delivers treatment with specific parameters including a 350 kHz frequency, 7 MPa peak pressure, 20-cycle pulse duration, and pulses repeated at 17 Hz. Each stone can receive up to 10 minutes of treatment, with a maximum of three stones treated per participant. Participants will be monitored during and after treatment through visual inspection of tissue with a ureteroscopic camera and assessment of stone fragments removed by basket. Safety is tracked by observing tissue injury and recording any adverse events or unexpected medical visits up to 120 days after the procedure. Effectiveness is measured by the volume of stone fragments smaller than 2 mm and the time taken to fully fragment the stones on the day of treatment. The study is conducted at two US centers and plans to treat up to 40 subjects.
CONDITIONS
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day 0
Participants undergo burst wave lithotripsy during their standard ureteroscopic stone removal procedure under anesthesia.
1 intraoperative visit (in-person)
Duration - Up to 120 days post-procedure
Participants are monitored for safety and effectiveness after the procedure, including adverse event assessments and stone fragmentation evaluation.
Approximately 3 to 4 follow-up visits
Total: 2 locations
1
IU Health North Hospital
Carmel, Indiana, United States, 46032
Actively Recruiting
2
University of Washington Medical Center
Seattle, Washington, United States, 98195
Actively Recruiting
M
Michael R Bailey, PhD, MS
B
Barbrina Dunmire
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Philip C May, Wayne Kreider, Adam D Maxwell...
https://pubmed.ncbi.nlm.nih.gov/28521550Adam D Maxwell, Bryan W Cunitz, Wayne Kreider...
https://pubmed.ncbi.nlm.nih.gov/25111910Michael R Bailey, Adam D Maxwell, Shunxiang Cao...
https://pubmed.ncbi.nlm.nih.gov/35229652Jonathan D Harper, Ian Metzler, Michael Kennedy Hall...
https://pubmed.ncbi.nlm.nih.gov/32940089